In this study, GFAP showed similar performances to pTau-181 in distinguishing Alzheimer’s disease from CU (P < 0.001) and MCI (P < 0.001) individuals, with a strong correlation with Aβ status. This evidence concerns the gene GFAP and Alzheimer disease.